Literature DB >> 22507872

Mycobacterium tuberculosis ManLAM inhibits T-cell-receptor signaling by interference with ZAP-70, Lck and LAT phosphorylation.

Robert N Mahon1, Obondo J Sande, Roxana E Rojas, Alan D Levine, Clifford V Harding, W Henry Boom.   

Abstract

Immune evasion is required for Mycobacterium tuberculosis to survive in the face of robust CD4(+) T cell responses. We have shown previously that M. tuberculosis cell wall glycolipids, including mannose capped lipoarabinomannan (ManLAM), directly inhibit polyclonal murine CD4(+) T cell activation by blocking ZAP-70 phosphorylation. We extended these studies to antigen-specific murine CD4(+) T cells and primary human T cells and found that ManLAM inhibited them as well. Lck and LAT phosphorylation also were inhibited by ManLAM without affecting their localization to lipid rafts. Inhibition of proximal TCR signaling was temperature sensitive, suggesting that ManLAM insertion into T cell membranes was required. Thus, M. tuberculosis ManLAM inhibits antigen-specific CD4(+) T cell activation by interfering with very early events in TCR signaling through ManLAM's insertion in T cell membranes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22507872      PMCID: PMC3352599          DOI: 10.1016/j.cellimm.2012.02.009

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  51 in total

Review 1.  Protein tyrosine phosphatases: from genes, to function, to disease.

Authors:  Nicholas K Tonks
Journal:  Nat Rev Mol Cell Biol       Date:  2006-11       Impact factor: 94.444

2.  TGF-beta inhibits IL-2 production and promotes cell cycle arrest in TCR-activated effector/memory T cells in the presence of sustained TCR signal transduction.

Authors:  Lopamudra Das; Alan D Levine
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

3.  ESAT-6 inhibits production of IFN-gamma by Mycobacterium tuberculosis-responsive human T cells.

Authors:  Xisheng Wang; Peter F Barnes; Karen M Dobos-Elder; James C Townsend; Yoon-tae Chung; Homayoun Shams; Stephen E Weis; Buka Samten
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

Review 4.  Negative feedback of T cell activation through inhibitory adapters and costimulatory receptors.

Authors:  Takashi Saito; Sho Yamasaki
Journal:  Immunol Rev       Date:  2003-04       Impact factor: 12.988

5.  Leishmania donovani lipophosphoglycan inhibits phagosomal maturation via action on membrane rafts.

Authors:  Martin E Winberg; Asa Holm; Eva Särndahl; Adrien F Vinet; Albert Descoteaux; Karl-Eric Magnusson; Birgitta Rasmusson; Maria Lerm
Journal:  Microbes Infect       Date:  2008-12-03       Impact factor: 2.700

Review 6.  The structure, regulation, and function of ZAP-70.

Authors:  Byron B Au-Yeung; Sebastian Deindl; Lih-Yun Hsu; Emil H Palacios; Susan E Levin; John Kuriyan; Arthur Weiss
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

7.  The immunogenic properties of protozoan glycosylphosphatidylinositols in the mosquito Anopheles gambiae.

Authors:  Romanico B G Arrighi; Françoise Debierre-Grockiego; Ralph T Schwarz; Ingrid Faye
Journal:  Dev Comp Immunol       Date:  2008-09-24       Impact factor: 3.636

8.  Incorporation of Mycobacterium tuberculosis lipoarabinomannan into macrophage membrane rafts is a prerequisite for the phagosomal maturation block.

Authors:  Amanda Welin; Martin E Winberg; Hana Abdalla; Eva Särndahl; Birgitta Rasmusson; Olle Stendahl; Maria Lerm
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

9.  Mycobacterium tuberculosis cell wall glycolipids directly inhibit CD4+ T-cell activation by interfering with proximal T-cell-receptor signaling.

Authors:  Robert N Mahon; Roxana E Rojas; Scott A Fulton; Jennifer L Franko; Clifford V Harding; W Henry Boom
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

10.  TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate during activation.

Authors:  Björn F Lillemeier; Manuel A Mörtelmaier; Martin B Forstner; Johannes B Huppa; Jay T Groves; Mark M Davis
Journal:  Nat Immunol       Date:  2009-12-13       Impact factor: 25.606

View more
  28 in total

1.  Comparative study of IgA VH 3 gene usage in healthy TST(-) and TST(+) population exposed to tuberculosis: deep sequencing analysis.

Authors:  Siang Tean Chin; Joshua Ignatius; Siti Suraiya; Gee Jun Tye; Maria E Sarmiento; Armando Acosta; Mohd Nor Norazmi; Theam Soon Lim
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

2.  "The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.

Authors:  Cesar Boggiano; Katrin Eichelberg; Lakshmi Ramachandra; Jaqueline Shea; Lalita Ramakrishnan; Samuel Behar; Joel D Ernst; Steven A Porcelli; Markus Maeurer; Hardy Kornfeld
Journal:  Vaccine       Date:  2017-05-02       Impact factor: 3.641

Review 3.  Extracellular vesicles and infectious diseases: new complexity to an old story.

Authors:  Jeffrey S Schorey; Clifford V Harding
Journal:  J Clin Invest       Date:  2016-04-01       Impact factor: 14.808

4.  Bacterial Membrane Vesicles Mediate the Release of Mycobacterium tuberculosis Lipoglycans and Lipoproteins from Infected Macrophages.

Authors:  Jaffre J Athman; Ying Wang; David J McDonald; W Henry Boom; Clifford V Harding; Pamela A Wearsch
Journal:  J Immunol       Date:  2015-06-24       Impact factor: 5.422

5.  The effect of siRNA-mediated lymphocyte-specific protein tyrosine kinase (Lck) inhibition on pulmonary inflammation in a mouse model of asthma.

Authors:  Shikui Zhang; Rongjia Yang; Yonghua Zheng
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis.

Authors:  W P Drake; B W Richmond; K Oswald-Richter; C Yu; J M Isom; J A Worrell; G R Shipley
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2013-11-25       Impact factor: 0.670

Review 7.  Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis.

Authors:  Joanne Turner; Jordi B Torrelles
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

8.  Aptamer against mannose-capped lipoarabinomannan inhibits virulent Mycobacterium tuberculosis infection in mice and rhesus monkeys.

Authors:  Qin Pan; Qilong Wang; Xiaoming Sun; Xianru Xia; Shimin Wu; Fengling Luo; Xiao-Lian Zhang
Journal:  Mol Ther       Date:  2014-02-27       Impact factor: 11.454

9.  Mannose-capped Lipoarabinomannan from Mycobacterium tuberculosis induces IL-37 production via upregulating ERK1/2 and p38 in human type II alveolar epithelial cells.

Authors:  Zhen Huang; Gao Wei Zhao; Chun Hai Gao; Xiu Wen Chi; Tao Zeng; Yan Wei Hu; Lei Zheng; Qian Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 10.  Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine Design.

Authors:  Joel D Ernst
Journal:  Cell Host Microbe       Date:  2018-07-11       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.